Financial Data Schedule. (Exhibit 27.1 is being submitted as an exhibit only in the electronic format of this Quarterly Report on Form 10-Q being submitted to the Securities and Exchange Commission. Exhibit 27.1 shall not be deemed filed for purposes of Section 11 of the Securities Act of 1933, Section 18 of the Securities Exchange Act of 1934 or Section 323 of the Trust Indenture Act, or otherwise be subject to the liabilities of such sections, nor shall it be deemed a part of any registration statement to which it relates.)
Financial Data Schedule. (1) Incorporated by reference to the indicated exhibit in Inhale's Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
(2) Incorporated by reference to the indicated exhibit in Inhale's Registration Statement on Form S-1 (No. 33-75942), as amended.
(3) Incorporated by reference to the indicated exhibit in Inhale's Registration Statement on Form S-1 (No. 33-89502), as amended.
Financial Data Schedule. (1) Previously filed as Exhibit 3.2 to our Registration Statement on Form S-1, Registration No. 333-33016.
(2) Previously filed as Exhibit 3.3 to our Registration Statement on Form S-1, Registration No. 333-33016.
(3) Previously filed as like-numbered Exhibit to our Registration Statement on Form S-1, Registration No. 333-33016.
Financial Data Schedule. Previously Filed.
(i) Previously filed as an Exhibit to the Company's Registration Statement on Form S-1 No. 33-90752.
(ii) Previously filed as an Exhibit to the Company's 10-K for the year ended December 31, 1995.
(iii) Previously filed as an Exhibit to the Company's 10-K for the year ended December 31, 1996.
(iv) Previously filed as an Exhibit to the Company's Current Report on 8-K dated September 29, 1997.
(v) Previously filed as an Exhibit to the Company's Current Report on 8-K dated January 6, 1998.
(vi) Previously filed as an Exhibit to the Company's Registration Statement on Form S-3 dated January 8, 1998.
(vii) Previously filed as an Exhibit to the Company's Registration Statement on Form S-8 dated January 14, 1998.
(viii) Previously filed as an Exhibit to the Company's 10-K for the year ended December 31, 1999 and as amended on April 7, 1999, February 23, 2000 and March 10, 2000.
(ix) Previously filed as an Exhibit to the Company's Report on Form 8-K dated November 1, 1999. + Management Contract or Compensatory Plan or Arrangement required to be filed as an exhibit to this report on Form 10-K. 1
1. Purposes of the Plan. The purposes of this Nonstatutory Stock Option Plan are: - to attract and retain the best available personnel for positions of substantial responsibility, - to provide additional incentive to Employees and Consultants, and - to promote the success of the Company's business. Options granted under the Plan will be Nonstatutory Stock Options.
Financial Data Schedule. (Exhibit 27.1 is being submitted as an exhibit only in the electronic format of this Quarterly Report on Form 10-Q being submitted to the Securities and Exchange Commission. Exhibit 27.1 shall not be deemed filed for purposes of Section 11 of the Securities Act of 1933, Section 18 of the Securities Exchange Act of 1934 or Section 323 of the Trust Indenture Act, or otherwise be subject to the liabilities of such sections, nor shall it be deemed a part of any registration statement to which it relates.)
99.1 Amended and Restated Credit Agreement among Global Marine Inc., Various Lending Institutions, Bankers Trust Company as Administrative Agent, Societe Generale as Managing Agent, and Christiania Bank OG Kreditkasse ASA New York Branch, Credit Lyonnais New York Branch, and the Bank of Nova Scotia as Co-Agents, Amended and Restated as of July 15, 1997.
Financial Data Schedule. Previously Filed.
Financial Data Schedule. Confidential treatment granted. SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Birmingham, State of Alabama, on this 28th day of March, 1997. BIOCRYST PHARMACEUTICALS, INC. BY: /S/ XXXXXXX X. XXXX ----------------------------------------- Xxxxxxx X. Xxxx, Ph.D. CHAIRMAN AND CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed by the following persons in the capacities indicated on March 28th, 1997: SIGNATURE TITLE(S) - ------------------------------ --------------------------- - ------------------------------ Officer and Director (Xxxxxxx X. Xxxx, Ph.D.) - ------------------------------ Officer and Director (J. Xxxxxx Xxxxxxx, M.D.) /s/ XXXX X. XXXXXXXXXX Secretary, Chief - ------------------------------ Scientific Officer and (Xxxx X. Xxxxxxxxxx, Ph.D.) Director /s/ XXXXXX X. XXXX Chief Financial Officer - ------------------------------ (Principal Financial and (Xxxxxx X. Xxxx) Accounting Officer) - ------------------------------ (Xxxxxxx X. Xxxxxxxxxxxxx) - ------------------------------ - ------------------------------ SIGNATURE TITLE(S) - ------------------------------ --------------------------- - ------------------------------ (Xxxxxxx X. Xxxxxxxxx, M.D.) - ------------------------------ (Xxxxxxx X. Xxxxxxx, III) - ------------------------------ (Xxxxxx X. Xxxxxxxx, Xx.) - ------------------------------ (Xxxxxxxx X. Xxxxx, M.D., Ph.D.) INDEX TO EXHIBITS SEQUENTIALLY NUMBERED NUMBER DESCRIPTION PAGE
3.1 Composite Certificate of Incorporation of Registrant. Incorporated by reference to Exhibit
3.1 to the Company's Form 10-Q for the second quarter ending June 30, 1995 dated August 11, 1995.
Financial Data Schedule. Confidential treatment granted. EXHIBIT 10.11 BIOCRYST PHARMACEUTICALS, INC. 0000 Xxxxxxx Xxxx Xxxxx Xxxxxxxxxx, Xxxxxxx 00000 December 17, l996
Financial Data Schedule. Previously Filed.
(i) Previously filed as an Exhibit to the Company's Registration Statement on Form S-1 No. 33-90752.
Financial Data Schedule. E-23 -------------------------
